ATN 151 Work-to-Prevent: Employment as HIV Prevention

University of North Carolina, Chapel Hill92 enrolled

Overview

The investigators aim to pilot-test a novel social and structural-level HIV intervention for YMSM and YTW of color ages 16-24.

Work2Prevent will advance the science by adapting, tailoring, and pilot-testing a novel social and structural-level HIV intervention for YMSM and YTW of color ages16-24 aimed at increasing economic stability (i.e., employment) through youth empowerment and asset development, and decreasing HIV risk behaviors (i.e., sex work) associated with social and economic marginalization.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

HIV Prevention

Interventions

Employment InterventionBEHAVIORAL

Participants will complete 4 workshop sessions in groups of 6-12. The workshop curriculum was based on the pre-existing iFOUR program, and tailored based on feedback from a Community Advisory Board (CAB), Focus Groups, and In Depth Interviews.

Eligibility

Sex: MALEMin age: 16 YearsMax age: 24 YearsHealthy volunteers:

Medical Language ↔ Plain English

Phase 2 Inclusion Criteria: 1. Being male or assigned male at birth (YTW) 2. Identifies as a man who has sex with men (YMSM) and/or a gay bisexual man or transgender woman/transwoman 3. Identifies as African American/Black or Hispanic/Latino 4. 16-24 years old 5. English-speaking (primary) 6. Currently unemployed but seeking employment, or employed only part-time (35 hrs or less on avg/wk) 7. Is able to attend a 4-session employment program Phase 2 Exclusion Criteria: 1. Individuals identifying as non-Hispanic White 2. Individuals not assigned male at birth 3. Individuals with a known HIV positive-status at time of consent Phase 3 Inclusion Criteria: 1. Being male or assigned male at birth (YTW) 2. Identifies as a man who has sex with men (YMSM) and/or a gay bisexual man or transgender woman/transwoman 3. Identifies as African American/Black or Hispanic/Latino 4. 16-24 years old 5. English-speaking (primary) 6. Currently unemployed but seeking employment, or employed only part-time (35 hrs or less on avg/wk) 7. Is able to attend a 4-session employment program 8. Did not participate in Phase 2 Phase 3 Exclusion Criteria: 1. Individuals identifying as non-Hispanic White 2. Individuals not assigned male at birth

Locations (1)

University of Chicago

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Information Systems Success Model Score

The Information Systems Success Model (ISSM) will be used to assess for intervention acceptability and satisfaction. The 21-item scale measures four sub-domains: information quality, handbook quality, perceived usefulness, and overall satisfaction. Every item is scored on a 1-5 scale, with 1 being "Strongly Disagree" and 5 being "Strongly Agree". Responses are averaged within each sub-domain to produce four sub-domain scores. The four sub-domain scores are then averaged to produce an overall ISSM score (1-5; higher scores indicate higher acceptability/satisfaction).

Time frame: Post-Intervention (up to 2 weeks after completion of intervention)

Number of Participants Completing Two or More Workshop Sessions

Workshop completion will be used to assess for intervention feasibility, as the workshop sessions are the intervention. Workshop completion will be defined as having attended at least two of the four workshop sessions and will be measured by tracking participant attendance.

Time frame: Post-Intervention (up to 2 weeks after completion of intervention)

Change From Baseline in Job Seeking Self-Efficacy Scale Score

Job seeking self-efficacy is defined as one's perceived ability and confidence to perform job search and application activities. The 12-item Job Seeking Self-Efficacy (JSS) scale uses response values on a 1-10 score, with 1 being "Not at All Confident" and 10 being "Very Confident". Responses are averaged to yield a total score, with higher scores indicating higher self-efficacy. Change in JSS will be calculated by subtracting the JSS score at baseline (T1) from the JSS score at the 8-month follow-up (T3) (-9 to +9; negative change indicates decreased self-efficacy, while positive change indicates increased self-efficacy).

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Protean Career Attitudes Scale Score

Protean career attitudes (PCAs) are defined as having self-direction in the pursuit of success in one's work. PCAs have previously been found to be associated with positive career satisfaction and self-perceived success. The validated 7-item scale measures two sub-domains: self-directed attitudes and values-driven attitudes. Every item is scored on a 1-5 scale, with 1 being "Strongly Disagree" and 5 being "Strongly Agree". Responses are averaged within each sub-domain to produce two sub-domain scores, which are then averaged as well to produce an overall PCA score. Change in PCA score will be calculated by subtracting the score at baseline (T1) from the score at the 8-month follow-up (T3) (-4 to +4; negative change indicates decreased PCAs, while positive change indicates increased PCAs).

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Secondary Outcomes

Change From Baseline in Self-Reported Hours Worked Per Week

Employment status will be assessed using self-reported average number of hours worked each week. Change in hours worked per week will be calculated by subtracting the baseline (T1) value from the follow-up (T3) value (negative change indicates fewer hours worked per week, while positive change indicates more hours work per week).

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Self-Reported Sexual Risk Behaviors

Sexual risk behaviors will be measured using 6 yes/no items assessing for engagement in the following behaviors during the past 6 months (this refers to the 6 months prior to the baseline visit for the first assessment and 6 months prior to the 8 month visit for the second assessment) for Phase 2, and the last 3 months for Phase 3: 1. condomless anal intercourse (CAI) with male partner of unknown HIV status 2. anal intercourse with 3 or more males 3. sex with male partner with a Sexually Transmitted Infection (STI) 4. CAI with HIV+ male partner 5. anal intercourse with condom failure 6. transactional sex work involvement Responses will be averaged at each assessment. Change in sexual risk behaviors will be calculated by subtracting the average at baseline from the average at the 8-month follow-up (range: -1 to +1; negative change indicates fewer sexual risk behaviors, while positive change indicates more sexual risk behaviors).

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Oral Chlamydia Test Result

Chlamydia infection will be assessed at baseline and follow-up using an oral sample. The test yields a positive (1) or negative (0) result. The number of positive test results at baseline and follow-up will be calculated.

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Anal Chlamydia Test Result

Chlamydia infection will be assessed at baseline and follow up using an anal sample. The test yields a positive (1) or negative (0) result. Number of positive test results at baseline and follow-up will be calculated.

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Urine Chlamydia Test Result

Chlamydia infection will be assessed at baseline and follow up using a urine sample. The test yields a positive (1) or negative (0) result. Number of positive test results at baseline and follow-up will be calculated.

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Oral Gonorrhea Test Result

Gonorrhea infection will be assessed at baseline and follow-up using an oral sample. The test yields a positive (1) or negative (0) result. Number of positive test results at baseline and follow-up will be calculated.

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Anal Gonorrhea Test Result

Gonorrhea infection will be assessed at baseline and follow-up using an anal sample. The test yields a positive (1) or negative (0) result. Number of positive test results at baseline and follow-up will be calculated.

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Change From Baseline in Urine Gonorrhea Test Result

Time frame: Baseline, Follow-Up (8 months for Phase 2, 3 months for Phase 3)

Reactive HIV Result or Reported New HIV+ Status

HIV infection will be assessed at follow-up using reactive HIV testing. Test results yield: Reactive or Non-reactive. Participants who reported HIV+ status will not be tested. A reactive HIV result will be defined as those with a "Reactive" result. Reported new HIV+ status is defined as those who report positive HIV status at follow-up and who were tested for HIV, with a non-reactive result, at baseline.

Time frame: Follow-Up (8 months for Phase 2, 3 months for Phase 3)